These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11106564)

  • 1. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation.
    Westphal V; Murch S; Kim S; Srikrishna G; Winchester B; Day R; Freeze HH
    Am J Pathol; 2000 Dec; 157(6):1917-25. PubMed ID: 11106564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic.
    Westphal V; Schottstädt C; Marquardt T; Freeze HH
    Mol Genet Metab; 2000 Jul; 70(3):219-23. PubMed ID: 10924277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation-Ic.
    Westphal V; Xiao M; Kwok PY; Freeze HH
    Hum Mutat; 2003 Nov; 22(5):420-1. PubMed ID: 14517965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy.
    Bode L; Eklund EA; Murch S; Freeze HH
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1015-23. PubMed ID: 15604198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.
    Bode L; Salvestrini C; Park PW; Li JP; Esko JD; Yamaguchi Y; Murch S; Freeze HH
    J Clin Invest; 2008 Jan; 118(1):229-38. PubMed ID: 18064305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis.
    Grünewald S; Imbach T; Huijben K; Rubio-Gozalbo ME; Verrips A; de Klerk JB; Stroink H; de Rijk-van Andel JF; Van Hove JL; Wendel U; Matthijs G; Hennet T; Jaeken J; Wevers RA
    Ann Neurol; 2000 Jun; 47(6):776-81. PubMed ID: 10852543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip.
    Rind N; Schmeiser V; Thiel C; Absmanner B; Lübbehusen J; Hocks J; Apeshiotis N; Wilichowski E; Lehle L; Körner C
    Hum Mol Genet; 2010 Apr; 19(8):1413-24. PubMed ID: 20080937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic.
    Imbach T; Grünewald S; Schenk B; Burda P; Schollen E; Wevers RA; Jaeken J; de Klerk JB; Berger EG; Matthijs G; Aebi M; Hennet T
    Hum Genet; 2000 May; 106(5):538-45. PubMed ID: 10914684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
    Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
    Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy.
    Bode L; Murch S; Freeze HH
    J Biol Chem; 2006 Mar; 281(12):7809-15. PubMed ID: 16434407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital disorder of glycosylation Ic in patients of Indian origin.
    Newell JW; Seo NS; Enns GM; McCraken M; Mantovani JF; Freeze HH
    Mol Genet Metab; 2003 Jul; 79(3):221-8. PubMed ID: 12855228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
    Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
    Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation.
    Eklund EA; Sun L; Yang SP; Pasion RM; Thorland EC; Freeze HH
    Biochem Biophys Res Commun; 2006 Jan; 339(3):755-60. PubMed ID: 16321363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij.
    Wu X; Rush JS; Karaoglu D; Krasnewich D; Lubinsky MS; Waechter CJ; Gilmore R; Freeze HH
    Hum Mutat; 2003 Aug; 22(2):144-50. PubMed ID: 12872255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy.
    Bode L; Freeze HH
    Biochim Biophys Acta; 2006 Apr; 1760(4):547-59. PubMed ID: 16380211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.
    Burda P; Borsig L; de Rijk-van Andel J; Wevers R; Jaeken J; Carchon H; Berger EG; Aebi M
    J Clin Invest; 1998 Aug; 102(4):647-52. PubMed ID: 9710431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies.
    Morava E; Tiemes V; Thiel C; Seta N; de Lonlay P; de Klerk H; Mulder M; Rubio-Gozalbo E; Visser G; van Hasselt P; Horovitz DDG; de Souza CFM; Schwartz IVD; Green A; Al-Owain M; Uziel G; Sigaudy S; Chabrol B; van Spronsen FJ; Steinert M; Komini E; Wurm D; Bevot A; Ayadi A; Huijben K; Dercksen M; Witters P; Jaeken J; Matthijs G; Lefeber DJ; Wevers RA
    J Inherit Metab Dis; 2016 Sep; 39(5):713-723. PubMed ID: 27287710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T911C (F304S) substitution in the human ALG6 gene is a common polymorphism and not a causal mutation of CDG-Ic.
    Vuillaumier-Barrot S; Le Bizec C; Durand G; Seta N
    J Hum Genet; 2001; 46(9):547-8. PubMed ID: 11558905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If.
    Schenk B; Imbach T; Frank CG; Grubenmann CE; Raymond GV; Hurvitz H; Korn-Lubetzki I; Revel-Vik S; Raas-Rotschild A; Luder AS; Jaeken J; Berger EG; Matthijs G; Hennet T; Aebi M
    J Clin Invest; 2001 Dec; 108(11):1687-95. PubMed ID: 11733564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition.
    Murch SH; Winyard PJ; Koletzko S; Wehner B; Cheema HA; Risdon RA; Phillips AD; Meadows N; Klein NJ; Walker-Smith JA
    Lancet; 1996 May; 347(9011):1299-301. PubMed ID: 8622507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.